ClinicalTrials.Veeva

Menu

Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial. (SCANX)

A

Applied Biologics

Status

Enrolling

Conditions

Ulcer
Diabetic Foot Ulcers (DFU)
Foot Ulcer Chronic
Diabetic Foot Ulcer

Treatments

Other: Blue Drop Foot Scanner

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT07360418
Pro00084454

Details and patient eligibility

About

Prospective long-term follow-up on durability of closure evaluated by photographic and thermal scanning.

Full description

This study is a follow-up durability trial from the CAMPX randomized controlled clinical trial. Only subjects who achieved complete closure at 12 weeks in the CAMPX trial will be evaluated. After signing the IRB-approved informed consent form, the subject will receive instruction on the BlueDrop® OneStep Foot Scanner™. In addition, written instructions on use will be provided. Subjects that are unable to use the scale will be asked to answer a questionnaire at 3, 6, 9, and 12 months after signing the consent form..

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The potential subject must have participated in the CAMPX trial and achieved complete closure by the 12-week endpoint.

Exclusion criteria

  • The potential subject did not participate in the CAMPX trial.
  • The potential subject participated in the CAMPX trial and did not achieve complete closure.

Trial design

50 participants in 1 patient group

OneStep Foot Scanner
Description:
This study is a follow-up durability trial from the CAMPX randomized controlled clinical trial. Only subjects who achieved complete closure at 12 weeks in the CAMPX trial will be evaluated. After signing the IRB-approved informed consent form, the subject will receive instruction on the BlueDrop® OneStep Foot Scanner™. In addition, written instructions on use will be provided. Subjects that are unable to use the scale will be asked to answer a questionnaire at 3, 6, 9, and 12 months after signing the consent form.
Treatment:
Other: Blue Drop Foot Scanner

Trial contacts and locations

1

Loading...

Central trial contact

Thomas Serena, MD; Bennett Sarver

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems